ArticleMicrobial ecology2026
Arsenic Speciation and Distribution in Three Hebeloma Species: Insights into Arsenic Handling and Transformation in Mycorrhizal Fungi.
Article in Microbial ecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arsenic accumulation and biotransformation in fungi remain poorly understood, particularly in mushrooms. This study investigated arsenic distribution, speciation, and detoxification mechanisms in three mushroom species of the genus Hebeloma: H. bulbiferum, H. sinapizans, and H. mesophaeum. Wild collected fruit bodies and laboratory mycelial cultures were analysed using size-exclusion chromatography (SEC) and ion-pair reversed-phase ICP-MS to determine total arsenic concentrations and speciation patterns. H. bulbiferum exhibited the highest arsenic accumulation in fruit bodies (up to 563 mg kg⁻¹ dry mass), predominantly as dimethylarsenate, whereas H. sinapizans accumulated less total As (up to 41.2 mg kg⁻¹ dry mass), comprising mainly arsenobetaine and dimethylarsenate, and H. mesophaeum (up to 4.2 mg kg⁻¹ dry mass) was dominated by inorganic arsenic and arsenocholine. SEC revealed that arsenic was present as low-molecular-weight fractions, although a minor protein-associated peak was observed in H. sinapizans, suggesting a possible presence of an arsenic-binding protein. Mycelial cultures demonstrated species-specific tolerance to arsenate and the ability to transform inorganic arsenic into organic arsenicals, with varying degrees of arsenate reduction, arsenite efflux, and methylation. In particular, H. sinapizans and H. mesophaeum exhibited a higher degree of As(III) efflux than H. bulbiferum, indicating a more efficient As reduction and export. Notably, some organoarsenicals, dimethylarsenate and trimethylarsine oxide, were actively excreted into the growth medium, indicating a role for mushroom mycelia in environmental arsenic cycling. These findings highlight distinct arsenic detoxification strategies in Hebeloma species, reveal fungal de novo arsenobetaine synthesis, and provide insights into arsenic transformation and sequestration in ectomycorrhizal mushrooms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.